Terms: = Lung cancer AND WT1, WAGR, 7490, ENSG00000184937, WT33, GUD, WIT-2 AND Diagnosis
95 results:
1. BAP1, Wilms' tumor 1, and calretinin in predicting survival and response to first-line chemotherapy in patients with pleural mesothelioma.
Yuce TH; Ak G; Metintas S; Dundar E; Roe OD; Panou V; Metintas M
J Cancer Res Clin Oncol; 2024 Jan; 150(2):38. PubMed ID: 38280040
[TBL] [Abstract] [Full Text] [Related]
2. Desmoplastic small round cell tumor of the abdomen: A case report.
Li R; Liu W; Ye L
Medicine (Baltimore); 2023 Nov; 102(45):e35965. PubMed ID: 37960784
[TBL] [Abstract] [Full Text] [Related]
3. [Analysis of clinicopathological features of 68 cases of malignant pleural mesothelioma].
Mei W; Yang SJ; Zhang YP; Fu QS; Xiong W; Zhao Y
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2023 Aug; 41(8):588-593. PubMed ID: 37667154
[No Abstract] [Full Text] [Related]
4. Comparison of immunohistochemical mesothelial biomarkers in paired biopsies and effusion cytology cell blocks from pleural mesothelioma.
Mansour MSI; Huseinzade A; Seidal T; Hejny K; Maty A; Taheri-Eilagh F; Mager U; Dejmek A; Dobra K; Brunnström H
Cytopathology; 2023 Sep; 34(5):456-465. PubMed ID: 37337638
[TBL] [Abstract] [Full Text] [Related]
5. Traditional Treatment Approaches and Role of Immunotherapy in lung Malignancy and Mesothelioma.
Tamanna MT; Egbune C
Cancer Treat Res; 2023; 185():79-89. PubMed ID: 37306905
[TBL] [Abstract] [Full Text] [Related]
6. Diffuse intrapulmonary mesothelioma mimicking pulmonary lepidic adenocarcinoma: a rare case report and review of the literature.
RanYue W; ChunYan W; Likun H; LiPing Z; JieLu L; ZhengWei D
Diagn Pathol; 2023 May; 18(1):64. PubMed ID: 37194050
[TBL] [Abstract] [Full Text] [Related]
7. [Cytopathological characterization of ascites for the diagnosis of serous ovarian carcinoma].
Chang YH; Zou BQ; Cai Y; Yang SD; Zhang Y; Liang JB; Li C
Zhonghua Zhong Liu Za Zhi; 2023 May; 45(5):424-432. PubMed ID: 37188628
[No Abstract] [Full Text] [Related]
8. [Mucinous tubular and spindle cell carcinoma of kidney: Clinicopathology and prognosis].
Shen Q; Liu YX; He Q
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):276-282. PubMed ID: 37042138
[TBL] [Abstract] [Full Text] [Related]
9. Clinical, Laboratory, Histological, Radiological, and Metabolic Features and Prognosis of Malignant Pleural Mesothelioma.
Zhang Y; Li R; Gu Y; LiZhu Y; Liu X; Zhang S
Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557076
[No Abstract] [Full Text] [Related]
10. [Primary Pericardial Malignant Mesothelioma:Report of a Case].
Nishikawa T; Takahashi M; Mori M; Okabayashi T; Kamikawa Y; Inoue F
Kyobu Geka; 2022 Nov; 75(12):1059-1061. PubMed ID: 36299163
[TBL] [Abstract] [Full Text] [Related]
11. Desmoplastic Small Round Cell Tumor of the Head and Neck: A Clinicopathological, Immunohistochemical and Molecular Analysis of Three Cases with Literature Review.
Sun M; Shao M; Jiang X; Yin T; Wang Q; Zhao L; Liu J; Lao IW; Yu L; Wang J
Int J Surg Pathol; 2023 Aug; 31(5):742-750. PubMed ID: 36172631
[TBL] [Abstract] [Full Text] [Related]
12. Multicenter study of diffuse pleural mesothelioma. Histopathological and immunohistochemical features.
Poleri C; Acosta Haab G; Falcoff N; Guman G; Dalurzo L; Iotti A; Martín ME; Olmedo G; Rayá M; Reginatto A; Werbach A; Demelli G; Labanca MJ; Leguina L; Mora MF
Medicina (B Aires); 2022; 82(2):210-216. PubMed ID: 35417384
[TBL] [Abstract] [Full Text] [Related]
13. wt1-AS/IGF2BP2 Axis Is a Potential Diagnostic and Prognostic Biomarker for lung Adenocarcinoma According to ceRNA Network Comprehensive Analysis Combined with Experiments.
Jia M; Shi Y; Xie Y; Li W; Deng J; Fu D; Bai J; Ma Y; Zuberi Z; Li J; Li Z
Cells; 2021 Dec; 11(1):. PubMed ID: 35011587
[TBL] [Abstract] [Full Text] [Related]
14. Joint prediction of solitary pulmonary module malignant probability based on logistic regression and malignant tendency comprehensive score.
Zhou S; Wang Q; Tang T; Cao M; Tan Y; Bai K; Liu W
J BUON; 2021; 26(5):1815-1823. PubMed ID: 34761588
[TBL] [Abstract] [Full Text] [Related]
15. Malignant mesothelioma: A clinicopathological study of 76 cases with emphasis on immunohistochemical evaluation along with review of the literature.
Patel T; Aswal P
Indian J Pathol Microbiol; 2021; 64(4):655-663. PubMed ID: 34673582
[TBL] [Abstract] [Full Text] [Related]
16. CLDN15 is a novel diagnostic marker for malignant pleural mesothelioma.
Watanabe M; Higashi T; Ozeki K; Higashi AY; Sugimoto K; Mine H; Takagi H; Ozaki Y; Muto S; Okabe N; Matsumura Y; Hasegawa T; Shio Y; Suzuki H; Chiba H
Sci Rep; 2021 Jun; 11(1):12554. PubMed ID: 34131154
[TBL] [Abstract] [Full Text] [Related]
17. Malignant Mesothelioma With
Ren H; Rassekh SR; Lacson A; Lee CH; Dickson BC; Chung CT; Lee AF
Pediatr Dev Pathol; 2021; 24(6):570-574. PubMed ID: 34121509
[TBL] [Abstract] [Full Text] [Related]
18. Utility of SOX6 and DAB2 for the diagnosis of Malignant Mesothelioma.
Naso JR; Cheung S; Ionescu DN; Churg A
Am J Surg Pathol; 2021 Sep; 45(9):1245-1251. PubMed ID: 33782226
[TBL] [Abstract] [Full Text] [Related]
19. GATA3 is a useful immunohistochemical marker for distinguishing sarcomatoid malignant mesothelioma from lung sarcomatoid carcinoma and organizing pleuritis.
Piao ZH; Zhou XC; Chen JY
Virchows Arch; 2021 Aug; 479(2):257-263. PubMed ID: 33570661
[TBL] [Abstract] [Full Text] [Related]
20. Unravelling the Role of LncRNA wt1-AS/miR-206/NAMPT Axis as Prognostic Biomarkers in lung Adenocarcinoma.
Li W; Liu Y; Li ZJ; Shi Y; Deng J; Bai J; Ma L; Zeng XX; Feng SS; Ren JL; Luo FJ; Rong DY; Chen XQ; Yin HQ; Chen Z; Da F
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33540574
[TBL] [Abstract] [Full Text] [Related]
[Next]
